Five vital anticoagulation reads from the summer

28.08.20151813
Cardiology Today has compiled coverage of major anticoagulation research recently published in journals, offering clinicians an overview of where the field stands in the use and effects of various therapies to manage CVD.

HARMONY: Ranolazine, dronedarone combination benefits patients with paroxysmal AF

27.08.20151832
Published data from the HARMONY trial confirm a previous report that moderate-dose ranolazine plus reduced-dose dronedarone was well-tolerated and reduced atrial fibrillation burden, according to a report in Circulation: Arrhythmia & Electrophysiology.

Experts from RSC and Antihypertensive League created a brochure for medical practitioners that integrates the most used scales and lists of cardiological risks.

25.08.20152333
Experts from RSC and Antihypertensive League created a brochure for medical practitioners that integrates the most used scales and lists of cardiological risks.

Atrial fibrillation risk increases with higher free thyroxine levels

25.08.20151551
Higher free thyroxine levels within the normal range increased the risk for atrial fibrillation, especially among younger adults, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

Edoxaban prevents VTE better than enoxaparin after total hip arthroplasty

24.08.20151608
Oral edoxaban showed superior to subcutaneous enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty, according to findings published in Thrombosis Journal.

Organic compound produced by intestinal bacteria linked to atherosclerosis, mortality

21.08.20151701
Trimethylamine-N-oxide, an organic compound produced by intestinal bacteria, was associated with coronary atherosclerosis burden and mortality among patients with chronic kidney disease in a recent study.

NAFLD may be linked to heart failure

20.08.20151534
In a cross-sectional analysis, researchers found that nonalcoholic fatty liver disease was independently associated with subclinical myocardial remodeling and dysfunction, which may indicate an association with heart failure.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.